Humana (NYSE:HUM) had its target price upped by equities research analysts at SunTrust Banks to $335.00 in a research report issued to clients and investors on Thursday, The Fly reports. The firm presently has a “hold” rating on the insurance provider’s stock. SunTrust Banks’ price objective would indicate a potential upside of 5.49% from the company’s previous close. SunTrust Banks also issued estimates for Humana’s Q4 2019 earnings at $2.22 EPS, FY2019 earnings at $17.78 EPS, Q1 2020 earnings at $4.80 EPS, Q2 2020 earnings at $5.94 EPS, Q3 2020 earnings at $5.04 EPS, Q4 2020 earnings at $2.86 EPS and FY2020 earnings at $18.64 EPS. The analysts noted that the move was a valuation call.
Other equities research analysts have also recently issued reports about the company. Cantor Fitzgerald raised Humana from a “neutral” rating to an “overweight” rating and lifted their target price for the company from $300.00 to $345.00 in a research note on Monday, August 12th. Piper Jaffray Companies lifted their target price on Humana from $315.00 to $341.00 and gave the company an “overweight” rating in a research note on Thursday, August 1st. JPMorgan Chase & Co. lifted their target price on Humana from $288.00 to $322.00 and gave the company an “overweight” rating in a research note on Thursday, August 1st. ValuEngine raised Humana from a “sell” rating to a “hold” rating in a research note on Wednesday, October 2nd. Finally, BMO Capital Markets cut Humana from an “outperform” rating to a “market perform” rating and lowered their target price for the company from $345.00 to $290.00 in a research note on Monday, September 30th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fourteen have given a buy rating to the stock. Humana presently has a consensus rating of “Buy” and an average price target of $322.63.
Shares of NYSE HUM traded up $2.44 during midday trading on Thursday, hitting $317.58. The stock had a trading volume of 1,173,375 shares, compared to its average volume of 1,220,728. The company’s 50-day simple moving average is $277.48 and its 200 day simple moving average is $270.93. The firm has a market cap of $39.82 billion, a P/E ratio of 21.83, a price-to-earnings-growth ratio of 1.27 and a beta of 0.85. Humana has a fifty-two week low of $225.65 and a fifty-two week high of $342.03. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.75 and a quick ratio of 1.75.
In other news, insider Brian P. Leclaire sold 7,239 shares of the firm’s stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $289.70, for a total value of $2,097,138.30. Following the transaction, the insider now directly owns 12,994 shares in the company, valued at approximately $3,764,361.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.54% of the stock is owned by company insiders.
Large investors have recently bought and sold shares of the company. Cornerstone Advisors Inc. lifted its holdings in Humana by 9.9% during the third quarter. Cornerstone Advisors Inc. now owns 388 shares of the insurance provider’s stock worth $99,000 after acquiring an additional 35 shares in the last quarter. Lindbrook Capital LLC lifted its holdings in Humana by 12.0% during the third quarter. Lindbrook Capital LLC now owns 327 shares of the insurance provider’s stock worth $84,000 after acquiring an additional 35 shares in the last quarter. Regentatlantic Capital LLC lifted its holdings in Humana by 0.4% during the second quarter. Regentatlantic Capital LLC now owns 9,617 shares of the insurance provider’s stock worth $2,551,000 after acquiring an additional 42 shares in the last quarter. Ballentine Partners LLC lifted its holdings in Humana by 2.5% during the third quarter. Ballentine Partners LLC now owns 1,751 shares of the insurance provider’s stock worth $448,000 after acquiring an additional 42 shares in the last quarter. Finally, Cim Investment Mangement Inc. lifted its holdings in Humana by 4.3% during the second quarter. Cim Investment Mangement Inc. now owns 1,125 shares of the insurance provider’s stock worth $298,000 after acquiring an additional 46 shares in the last quarter. Institutional investors and hedge funds own 92.93% of the company’s stock.
Humana Company Profile
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Recommended Story: How does the Beige Book influence monetary policy?
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.